The highest sensitivity of NSCLC early stages detection (92%) was observed for CA-62 marker as compared to CEA, CYFRA 21–1 and SCC tumor markers, which are already used in the diagnosis and monitoring of LC (9, 24). This evidence concerns the gene CEACAM5 and laryngotracheoesophageal cleft.